Clinical Trials
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Clinical Trials | 10 February 2012
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
Clinical Trials | 09 February 2012
-
Agilent Technologies’s Thought Leader Award supports Chris Evelo’s work at Maastricht University
Agilent Technologies the Agilent Technologies Foundation announced that Dr Chris Evelo and the department of bioinformatics at Maastricht University are the recipients of an Agilent Thought Leader Award supporting development of software to integrate different types of biological data. The goal of this award is to help accelerate breakthroughs in disease research by facilitating integrative systems biology approaches.
Clinical Trials | 06 February 2012
-
Phase III studies with VEGF Trap-Eye in wet age-related macular degeneration show sustained improvement in visual acuity
Bayer HealthCare and Regeneron Pharmaceuticals announced that in an integrated analysis of two parallel Phase III studies (VIEW 1 and VIEW 2) in patients with the neovascular form of age-related macular degeneration (wet AMD), patients treated with VEGF Trap-Eye showed a sustained improvement in visual acuity at 96 weeks versus baseline.
Clinical Trials | 25 January 2012
-
Molecular Profiles invests in new facility to increase manufacturing capabilities for clinical trials
Molecular Profiles, a leading specialist contract research and manufacturing organization, announces the commencement of construction of a new manufacturing facility. This £9 million investment will allow Molecular Profiles to expand its current manufacturing capabilities while strengthening its existing expertise in the drug development field.
Clinical Trials | 19 January 2012
-
ICON wins award at the Annual Scrip Awards
ICON has won the Clinical Research Team of the Year award at the annual 2011 Scrip Awards.
Clinical Trials | 18 January 2012
-
PBL InterferonSource collaborates with AVANZA
PBL InterferonSource (PBL) and AVANZA Laboratories announced collaboration between their two organizations that will focus on enhancing their ability to service the biopharmaceutical industry.
Clinical Trials | 13 January 2012
-
ICON Acquires BeijingWits Medical Consulting
ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.
Clinical Trials | 11 January 2012
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
Clinical Trials | 09 January 2012
-
ViroMed receives approval for Phase II trial in the US for diabetic peripheral neuropathy
ViroMed announced that VM202-DPN, the company's proprietary DNA medicine for treatment of diabetic peripheral neuropathy, has received approval from the US FDA for a Phase II clinical trial.
Clinical Trials | 04 January 2012
